Tissue remodelling in the adrenal gland

Biochemical Pharmacology

Volumn 56, Issue 2, 1998, Pages 163-171

  Wolkersdörfer, Gernot W ^a   Bornstein, Stefan R ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Adrenal gland; Apoptosis; Interaction; Zonation

Indexed keywords

ANGIOTENSIN RECEPTOR; CORTICOTROPIN; CYCLINE; POLYPEPTIDE;

ADRENAL GLAND; APOPTOSIS; CELL COMMUNICATION; CELL DEATH; CELL PROLIFERATION; HUMAN; HUMAN TISSUE; IMMUNE SYSTEM; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW;

EID: 0344863168     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00067-7     Document Type: Article

References (96)

1. Nussdorfer GG, Cytophysiology of the adrenal cortex. Int Rev Cytol 98: 1-405, 1986.
2. Bornstein SR, Ehrhart-Bornstein M and Scherbaum WA, Morphological and functional studies of the paracrine interaction between cortex and medulla in the adrenal gland. Microsc Res Tech 36: 520-533, 1997.
3. Ehrhart-Bornstein M, Bornstein SR and Scherbaum WA, Sympathoadrenal system and immune system in the regulation of adrenocortical function. Eur J Endocrinol 135: 19-26, 1996.
4. Hoerr NL, The cells of the suprarenal cortex in the guinea-pig. Am J Anat 48: 139-197, 1931.
5. Kerr JF, Wyllie AH and Currie AR, Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257, 1972.
6. Thompson HJ, Strange R and Schedin PJ, Apoptosis in the genesis and prevention of cancer. Cancer Epidemiol Biomarkers Prev 1: 597-602, 1992.
7. Idelman S, Ultrastructure of the mammalian adrenal cortex. Int Rev Cytol 27: 181-281, 1970.
8. Kerr JF, Shrinkage necrosis of adrenal cortical cells. J Pathol 107: 217-219, 1972.
9. Wyllie AH, Kerr JF and Currie AR, Cell death in the normal neonatal rat adrenal cortex. J Pathol 111: 255-261, 1973.
10. Wyllie AH, Kerr JF, Macaskill IA and Currie AR, Adrenocortical cell deletion: The role of ACTH. J Pathol 111: 85-94, 1973.
11. Gottschau M, Structur und embryonale Entwicklung der Nebenniere bei Säugetieren. Arch Anat Physiol 8: 412-457, 1883.
12. da Costa C, Histophysiologie du cortex surrenal. Ann Endocrinol (Paris) 12: 361-403, 1951.
13. Idelman S, General comparative and clinical endocrinology of adrenal cortex. In: Adrenal Cortex (Ed. Jones IC), pp. 1-199. Academic Press, London, 1978.
14. Sugihara H, Kawai K and Tsuchiyama H, Effects of exogenous ACTH on the rat fetal adrenal cortex: A histochemical and electron-microscopical observation. Acta Pathol Jpn 27: 477-484, 1977.
15. Orenberg EK and Glick D, Quantitative histologic distribution of adenosine-3′,5′-monophosphate in the rat adrenal and effect of adrenocorticotropin. J Histochem Cytochem 20: 923-928, 1972.
16. Colder MP and Boyns AR, Distribution of adrenocorticotrophic hormone-stimulated adenylate cyclase in the adrenal cortex. J Endocrinol 56: 471-481, 1973.
17. Belloni AS, Mazzocchi G, Meneghelli V and Nussdorfer GG, Cytogenesis in the rat adrenal cortex: Evidence for an ACTH-induced centripetal cell migration from the zona glomerulosa. Arch Anat Histol Embryol 61: 195-205, 1978.
18. Yoffey JM, The suprarenal cortex: The structural background. In: The Suprarenal Cortex (Ed. Yoffey JM), pp. 31-38. Academic Press, New York, 1953.
19. Tonutti E, Über die strukturelle Funktionsanpassung der Nebennierenrinde. Endokrinologie 28: 1-15, 1951.
20. Chester-Jones I, The Adrenal Cortex. Cambridge University Press, London, 1957.
21. Swann HG, The pituitary-adrenocortical relationship. Physiol Rev 20: 493-521, 1940.
22. Sarason EL, Morphological changes in the rat's adrenal cortex under various experimental conditions. Arch Pathol 35: 373-390, 1997.
23. Malendowicz LK, Robba C and Nussdorfer GG, Sex differences in adrenocortical structure and function. XXII. Light-and electron-microscopic morphometric studies on the effects of gonadectomy and gonadal hormone replacement on the rat adrenal cortex. Cell Tissue Res 244: 141-145, 1986.
24. Nag B, Arimilli S, Mukku PV and Astafieva I, Functionally active recombinant α and β chain-peptide complexes of human major histocompatibility class II molecules. J Biol Chem 271: 10413-10418, 1996.
25. Compton MM, A biochemical hallmark of apoptosis: Internucleosomal degradation of the genome. Cancer Metastasis Rev 11: 105-119, 1992.
26. Sasano H, Imatani A, Shizawa S, Suzuki T and Nagura H, Cell proliferation and apoptosis in normal and pathologic human adrenal. Mod Pathol 8: 11-17, 1995.
27. Wolkersdorfer GW, Ehrhart-Bornstein M, Brauer S, Marx C, Scherbaum WA and Bornstein SR, Differential regulation of apoptosis in the normal human adrenal gland. J Clin Endocrinol Metab 81: 4129-4136, 1996.
28. Clauser E, Curnow KM, Davies E, Conchon S, Teutsch B, Vianello B, Monnot C and Corvol P, Angiotensin II receptors: Protein and gene structures, expression and potential pathological involvements. Eur J Endocrinol 134: 403-411, 1996.
29. 2 receptor mRNA during development of rat kidney and adrenal gland. Am J Physiol 268: F922-F930, 1995.
30. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y and Nagata S, The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66: 233-243, 1991.
31. Trauth BC, Klas C, Peters AM, Matzku S, Moller P, Falk W, Debatin KM and Krammer PH, Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245: 301-305, 1989.
32. Leithäuser F, Dhein J, Mechtersheimer G, Koretz K, Brüderlein S, Henne C, Schmidt A, Debatin K-M, Krammer PH and Möller P, Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 69: 415-429, 1993.
33. (WAF1/CIP1/SDI1) and p53 in apoptopic cells in the adrenal cortex and induction by ischemia/reperfusion injury. J Clin Invest 97: 1723-1731, 1996.
34. Reincke M, Karl M, Travis WH, Mastorakos G, Allolio B, Linehan HM and Chrousos GP, p53 mutations in human adrenocortical neoplasms: Immunohistochemical and molecular studies. J Clin Endocrinol Metab 78: 790-794, 1994.
35. Lin S-R, Lee Y-J and Tsai J-H, Mutations of the p53 gene in human functional adrenal neoplasms. J Clin Endocrinol Metab 78: 483-491, 1994.
36. Gupta P, Franco-Saenz R and Mulrow PJ, Locally generated angiotensin II in the adrenal gland regulates basal, corticotropin-, and potassium-stimulated aldosterone secretion. Hypertension 25: 443-448, 1995.
37. Bahr V, Sander-Bähr C, Hensen J and Oelkers W, Influence of sodium and potassium diets on adrenal vasopressin content and direct effects of vasopressin on aldosterone synthesis in adrenocortical cells. Horm Metab Res 25: 411-416, 1993.
38. Shanmugam S, Monnot C, Corvol P and Gasc J-M, Distribution of type I angiotensin II receptor subtype messenger RNAs in the rat fetus. Hypertension 23: 137-141, 1994.
39. Redmann A, Mobius K, Hiller HH, Oelkers W and Bahr V, Ascorbate depletion prevents aldosterone stimulation by sodium deficiency in the guinea pig. Eur J Endocrinol 133: 499-506, 1995.
40. Ho MM and Vinson GP, Endocrine control of the distribution of basic fibroblast growth factor, insulin-like growth factor-I and transforming growth factor-β, mRNAs in adult rat adrenals using non-radioactive in situ hybridization. J Endocrinol 144: 379-387, 1995.
41. Gerdes J, Lemke H, Baisch H, Wacker H-H, Schwab U and Stein H, Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710-1715, 1984.
42. Le Houx JG and Ducharme L, In vivo effects of adrenocorticotropin on c-jun, jun-B, c-fos and fos-B in rat adrenal. Endocr Res 21: 267-274, 1995.
43. Liu J, Voutilainen R, Kahri AI and Heikkilä P, Expression of the c-myc gene in human adrenals: Regulation by adrenocorticotropin in primary cultures. J Endocrinol 148: 523-529, 1996.
44. Viard I, Hall SH, Jaillard C, Berthelon MC and Saez JM, Regulation of c-fos, c-jun and jun-B messenger ribonucleic acids by angiotensin-II and corticotropin in ovine and bovine adrenocortical cells. Endocrinology 130: 1193-1200, 1992.
45. King KL and Cidlowski JA, Cell cycle and apoptosis: Common pathways to life and death. J Cell Biochem 58: 175-180, 1995.
46. Buttyan R, Zakeri Z, Lockshin R and Wolgemuth D, Cascade induction of c-fos, c-myc, and heat shock 70K transcripts during regression of the rat ventral prostate gland. Mol Endocrinol 2: 650-657, 1988.
47. Mathews MB, Bernstein RM, Franza BR Jr and Garrels JI, Identity of the proliferating cell nuclear antigen and cyclin. Nature 309: 374-376, 1984.
48. Shivji KK, Kenny MK and Wood RD, Proliferating cell nuclear antigen is required for DNA excision repair. Cell 69: 367-374, 1992.
49. Waseem NH and Lane DP, Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. J Cell Sci 96: 121-129, 1990.
50. Munari-Silem Y, Lebrethon MC, Morand I, Rousset B and Saez JM, Gap junction-mediated cell-to-cell communication in bovine and human adrenal cells. A process whereby cells increase their responsiveness to physiological corticotropin concentrations. J Clin Invest 95: 1429-1439, 1995.
51. Murray SA, Oyoyo UA, Pharrams SY, Kumar NM and Gilula NB, Characterization of gap junction expression in the adrenal gland. Endocr Res 21: 221-229, 1995.
52. Bornstein SR, Ehrhart-Bornstein M and Scherbaum WA, Ultrastructural evidence for cortico-chromaffin hybrid cells in rat adrenals? Endocrinology 129: 1113-1115, 1991.
53. Ehrhart-Bornstein M, Bornstein SR, Trzeclak WH, Usadel H, Guse-Behling H, Waterman MR and Scherbaum WA, Adrenaline stimulates cholesterol side-chain cleavage cytochrome P450 mRNA accumulation in bovine adrenocortical cells. J Endocrinol 131: R5-R8, 1991.
54. Bornstein SR, González-Hernández JA, Ehrhart-Bornstein M, Adler G and Scherbaum WA, Intimate contact of chromaffin and cortical cells within the human adrenal gland forms the cellular basis for important intraadrenal interactions. J Clin Endocrinol Metab 78: 225-232, 1994.
55. Chrousos GP, The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332: 1351-1362, 1995.
56. Axelrod J and Reisine TD, Stress hormones: Their interaction and regulation. Science 224: 452-459, 1984.
57. Besedovsky HO and del Rey A, Immune-neuro-endocrine interactions: Facts and hypotheses. Endo Rev 17: 64-102, 1996.
58. González-Hernández JA, Bornstein SR, Ehrhart-Bornstein M, Geschwend JE, Adler G and Scherbaum WA, Macrophages within the human adrenal gland. Cell Tissue Res 278: 201-205, 1994.
59. Nathan CF, Secretory products of macrophages. J Clin Invest 79: 319-326, 1987.
60. Germain RN, MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation. Cell 76: 287-299, 1994.
61. Khoury EL, Greenspan JS and Greenspan FS, Adrenocortical cells of the zona reticularis normally express HLA-DR antigenic determinants. Am J Pathol 127: 580-591, 1987.
62. McNicol AM, Class II MHC antigen expression in adrenal cortex. Lancet 2: 1282, 1986.
63. Marx C, Wolkersdörfer GW, Brown JW, Scherbaum WA and Bornstein SR, MHC class II expression - A new tool to assess dignity in adrenocortical tumours. J Clin Endocrinol Metab 81: 4488-4491, 1996.
64. Wolkersdörfer GW, Marx C, Brown JW, Scherbaum WA and Bornstein SR, Evaluation of apoptotic parameters in normal and neoplastic human adrenal. Endocr Res 22: 411-419, 1996.
65. McConkey DJ, Hartzell P, Chow SC, Orrenius S and Jondal M, Interleukin 1 inhibits T cell receptor-mediated apoptosis in immature thymocytes. J Biol Chem 265: 3009-3011, 1990.
66. González-Hernández JA, Bornstein SR, Ehrhart-Bornstein M, Gschwend JE, Gwosdow A, Jirikowski G and Scherbaum WA, IL-1 is expressed in human adrenal gland in vivo. Possible role in a local immune-adrenal axis. Clin Exp Immunol 99: 137-141, 1995.
67. González-Hernández JA, Bornstein SR, Ehrhart-Bornstein M, Spath-Schwalbe E, Jirikowski G and Scherbaum WA, Interleukin-6 messenger ribonucleic acid expression in human adrenal gland in vivo: New clue to a paracrine or autocrine regulation of adrenal function. J Clin Endocrinol Metab 79: 1492-1497, 1994.
68. González-Hernández JA, Ehrhart-Bornstein M, Späth-Schwalbe E, Scherbaum WA and Bornstein SR, Human adrenal cells express tumor necrosis factor-α messenger ribonucleic acid: Evidence for paracrine control of adrenal function. J Clin Endocrinol Metab 81: 807-813, 1996.
69. Pfizenmaier K, Scheurich P, Schlüter C and Krönke M, Tumor necrosis factor enhances HLA-A,B,C and HLA-DR gene expression in human tumor cells. J Immunol 138: 975-980, 1987.
70. Watanabe Y and Jacob CO, Regulation of MHC class II antigen expression. Opposing effects of tumor necrosis factor-α on IFN-γ-induced HLA-DR and Ia expression depends on the maturation and differentiation stage of the cell. J Immunol 146: 899-905, 1991.
71. Harley CB, Futcher AB and Greider CW, Telomeres shorten during ageing of human fibroblasts. Nature 345: 458-460, 1990.
72. Negoescu A, Labat-Moleur F, Defaye G, Mezin P, Drouet C, Brambilla E, Chambaz EM and Feige JJ, Contribution of apoptosis to the phenotypic changes of adrenocortical cells in primary culture. Mol Cell Endocrinol 110: 175-184, 1995.
73. Morley SD, Viard I, Chung B-C, Ikeda Y, Parker KL and Mullins JJ, Variegated expression of a mouse steroid 21-hydroxylase/β-galactosidase transgene suggests centripetal migration of adrenocortical cells. Mol Endocrinol 10: 585-598, 1996.
74. Tian Y, Balla T, Baukal AJ and Catt KJ, Growth responses to angiotensin II in bovine adrenal glomerulosa cells. Am J Physiol 268: E135-E144, 1995.
75. McEwan PE, Lindop GB and Kenyon CJ, In vivo studies of the control of DNA synthesis in the rat adrenal cortex and medulla. Endocr Res 21: 91-102, 1995.
76. Mitani F, Ogishima T, Miyamoto H and Ishimura Y, Localization of P450aldo and P45011 beta in normal and regenerating rat adrenal cortex. Endocr Res 21: 413-423, 1995.
77. Bornstein SR, Ehrhart M, Scherbaum WA and Pfeiffer EF, Adrenocortical atrophy of hypophysectomized rats can be reduced by corticotropin-releasing hormone (CRH). Cell Tissue Res 260: 161-166, 1990.
78. Tun RY, Smith MD, Lo SS, Rook GA, Lydyard P and Leslie RD, Antibodies to heat shock protein 65 kD in type 1 diabetes mellitus. Diabet Med 11: 66-70, 1994.
79. 1 receptor: Gain-of-function study using gene transfer. Proc Natl Acad Sci USA 92: 10663-10667, 1995.
80. Yamada T, Horiuchi M and Dzau VJ, Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci USA 93: 156-160, 1996.
81. Blauer KL, Poth M, Rogers WM and Bernton EW, Dehydroepiandrosterone antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinology 129: 3174-3179, 1991.
82. Bamberger CM and Chrousos GP, The glucocorticoid receptor and RU 486 in man. Ann NY Acad Sci 761: 296-310, 1995.
83. Hayashi Y, Hiyoshi T, Takemura T, Kurashima C and Hirokawa K, Focal lymphocytic infiltration in the adrenal cortex of the elderly: Immunohistological analysis of infiltrating lymphocytes. Clin Exp Immunol 77: 101-105, 1989.
84. Dhabhar FS, Miller AH, McEwen BS and Spencer RL, Stress-induced changes in blood leukocyte distribution. Role of adrenal steroid hormones. J Immunol 157: 1638-1644, 1996.
85. Dhein J, Walczak H, Baumler C, Debatin KM and Krammer PH, Autocrine T-cell suicide mediated by APO-1/(Fas/ CD95). Nature 373: 438-441, 1995.
86. Brunner T, Mogil RJ, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF and Green DR, Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373: 441-444, 1995.
87. Truman JP, Ericson ML, Choqueux-Seebold CJ, Charron DJ and Mooney NA, Lymphocyte programmed cell death is mediated via HLA class II DR. Int Immunol 6: 887-896, 1994.
88. Yoshino T, Cao L, Nishiuchi R, Matsuo Y, Yamadori I, Kondo E, Teramoto N, Hayashi K, Takahashi K, Kamikawaji N and Akagi T, Ligation of HLA class II molecules promotes sensitivity to CD95 (Fas antigen, APO-1)-mediated apoptosis. Eur J Immunol 25: 2190-2194, 1995.
89. Lynch DH, Biology of Fas. Circ Shock 44: 63-66, 1994.
90. Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA, Goodwin RG, Smith CA, Ramsdell F and Lynch DH, Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 181: 71-77, 1995.
91. Newell MK, VanderWall J, Beard KS and Freed JH, Ligation of major histocompatibility complex class II molecules mediates apoptotic cell death in resting B lymphocytes. Proc Natl Acad Sci USA 90: 10459-10463, 1993.
92. Arimilli S, Mumm JB and Nag B, Antigen-specific apoptosis in immortalized T cells by soluble MHC class II-peptide complexes. Immunol Cell Biol 74: 96-104, 1996.
93. Weiss LM, Medeiros LJ and Vickery AL Jr, Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 13: 202-206, 1989.
94. Oelkers W, Diagnostic puzzle of the adrenal "incidentaloma." Eur J Endocrinol 132: 419-421, 1995.
95. Hirokawa K, Utsuyama M, Kasai M and Kurashima C, Aging and immunity. Acta Pathol Jpn 42: 537-548, 1992.
96. Weksler ME, Immune senescence and adrenal steroids: Immune dysregulation and the action of dehydroepiandrosterone (DHEA) in old animals. Eur J Clin Pharmacol 45(Suppl 1): S21-S24, 1993.